parkinson glutathione oxidative ipsc crispr Stem cells strike back: advancements in Alzheimer's and Parkinson's disease treatment and modeling efforts from 2019 to 2024 | Journal of Molecular Medicine Treatment of Parkinson's Disease through
Treatment of Parkinson's Disease through Personalized Medicine and Induced Pluripotent Stem Cells PMC Frontiers Mitochondrial Dysfunction in Parkinson's Disease: From Mechanistic Insights to Therapy CRISPR And iPSC Disease Modeling And Drug Screening Alpha synuclein determines ferroptosis sensitivity in dopaminergic neurons via modulation of ether phospholipid membrane composition: Cell Reports
Pay in 4 interest-free payments of $5.68 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



